Skip to main content

Journal of Cancer Research and Clinical Oncology

Ausgabe 12/2015

Inhalt (17 Artikel)

Original Article – Cancer Research

Novel EGFR-specific immunotoxins based on panitumumab and cetuximab show in vitro and ex vivo activity against different tumor entities

Judith Niesen, Christoph Stein, Hannes Brehm, Grit Hehmann-Titt, Rolf Fendel, Georg Melmer, Rainer Fischer, Stefan Barth

Original Article – Cancer Research

Hypermethylation of ITGA4, TFPI2 and VIMENTIN promoters is increased in inflamed colon tissue: putative risk markers for colitis-associated cancer

Christian Gerecke, Bettina Scholtka, Yvonne Löwenstein, Isabel Fait, Uwe Gottschalk, Dorothee Rogoll, Ralph Melcher, Burkhard Kleuser

Open Access Original Article – Cancer Research

Significances of contactin-1 expression in human gastric cancer and knockdown of contactin-1 expression inhibits invasion and metastasis of MKN45 gastric cancer cells

De-Hu Chen, Ji-Wei Yu, Ju-Gang Wu, Shou-Lian Wang, Bo-Jian Jiang

Original Article – Cancer Research

Clinicopathological significance of cancer stem-like cell markers in high-grade neuroendocrine carcinoma of the lung

Masahiro Morise, Tomoyuki Hishida, Akiko Takahashi, Junji Yoshida, Yuichiro Ohe, Kanji Nagai, Genichiro Ishii

Original Article – Cancer Research

Changing incidence of myeloproliferative neoplasms: trends and subgroup risk profiles in the USA, 1973–2011

Melissa A. Deadmond, Julie A. Smith-Gagen

Original Article – Cancer Research

The prognostic significance of HOTAIR for predicting clinical outcome in patients with digestive system tumors

Gaoxiang Ma, Qiaoyan Wang, Chunye Lv, Fulin Qiang, Qiuhan Hua, Haiyan Chu, Mulong Du, Na Tong, Yejuan Jiang, Meilin Wang, Zhengdong Zhang, Jian Wang, Weida Gong

Original Article – Cancer Research

Association between MutL homolog 1 polymorphisms and the risk of colorectal cancer: a meta-analysis

Haiyan Chen, Zhujing Shen, Yeting Hu, Qian Xiao, Dikai Bei, Xiangfeng Shen, Kefeng Ding

Open Access Original Article – Cancer Research

Expression profiling of receptor tyrosine kinases in high-grade neuroendocrine carcinoma of the lung: a comparative analysis with adenocarcinoma and squamous cell carcinoma

Yuki Matsumura, Shigeki Umemura, Genichiro Ishii, Koji Tsuta, Shingo Matsumoto, Keiju Aokage, Tomoyuki Hishida, Junji Yoshida, Yuichiro Ohe, Hiroyuki Suzuki, Atsushi Ochiai, Koichi Goto, Kanji Nagai, Katsuya Tsuchihara

Review – Clinical Oncology

Patient-reported outcomes in randomised controlled trials of colorectal cancer: an analysis determining the availability of robust data to inform clinical decision-making

Jonathan R. Rees, Katie Whale, Daniel Fish, Peter Fayers, Valentina Cafaro, Andrea Pusic, Jane M. Blazeby, Fabio Efficace

Original Article – Clinical Oncology

Comparable outcome after single-antigen-mismatched versus matched unrelated donor haematopoietic cell transplantation

A. Rockstroh, H. K. Al-Ali, T. Lange, W. Pönisch, R. Krahl, M. Cross, G. Behre, D. Niederwieser, C. Pfrepper

Original Article – Clinical Oncology

Bendamustine in heavily pre-treated patients with relapsed or refractory multiple myeloma

Elisabeth Stöhr, Frederic Carsten Schmeel, Leonard Christopher Schmeel, Mathias Hänel, Ingo G. H. Schmidt-Wolf

Original Article – Clinical Oncology

Prognostic significance of platelet-derived growth factor receptor-β expression in localized clear cell renal cell carcinoma

Myungsun Shim, Cheryn Song, Sejun Park, Seung-Kwon Choi, Yong Mee Cho, Choung-Soo Kim, Hanjong Ahn

Original Article – Clinical Oncology

Wilms tumor gene single nucleotide polymorphism rs16754 predicts a favorable outcome in children with acute lymphoblastic leukemia

Anne-Sophie Junghanns, Susan Wittig, Caroline Woehlecke, Thomas Lehmann, Clemens Arndt, Bernd Gruhn

Open Access Original Article – Clinical Oncology

Adjuvant endocrine therapy in pre- versus postmenopausal patients with steroid hormone receptor-positive breast cancer: results from a large population-based cohort of a cancer registry

E. C. Inwald, M. Koller, M. Klinkhammer-Schalke, F. Zeman, F. Hofstädter, P. Lindberg, M. Gerstenhauer, S. Schüler, O. Treeck, O. Ortmann

Original Article – Clinical Oncology

Poor graft function can be durably and safely improved by CD34+-selected stem cell boosts after allogeneic unrelated matched or mismatched hematopoietic cell transplantation

Sebastian P. Haen, Michael Schumm, Christoph Faul, Lothar Kanz, Wolfgang A. Bethge, Wichard Vogel

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.